News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Pirtobrutinib scores a phase III win in BTKi-pretreated CLL/SLL
14 Jan 2025
byMike Ng
The first phase III trial of pirtobrutinib in haematologic malignancies to readout has demonstrated superiority over investigator's choice in delaying progression in pretreated chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL), with results from the BRUIN CLL-321 study first presented at ASH 2024.
14 Jan 2025








